357 related articles for article (PubMed ID: 17629950)
1. Endogenous and synthetic neurosteroids in treatment of Niemann-Pick Type C disease.
Mellon SH; Gong W; Schonemann MD
Brain Res Rev; 2008 Mar; 57(2):410-20. PubMed ID: 17629950
[TBL] [Abstract][Full Text] [Related]
2. Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone.
Griffin LD; Gong W; Verot L; Mellon SH
Nat Med; 2004 Jul; 10(7):704-11. PubMed ID: 15208706
[TBL] [Abstract][Full Text] [Related]
3. Niemann pick type C disease as a model for defects in neurosteroidogenesis.
Mellon S; Gong W; Griffin LD
Endocr Res; 2004 Nov; 30(4):727-35. PubMed ID: 15666818
[TBL] [Abstract][Full Text] [Related]
4. Allopregnanolone treatment delays cholesterol accumulation and reduces autophagic/lysosomal dysfunction and inflammation in Npc1-/- mouse brain.
Liao G; Cheung S; Galeano J; Ji AX; Qin Q; Bi X
Brain Res; 2009 May; 1270():140-51. PubMed ID: 19328188
[TBL] [Abstract][Full Text] [Related]
5. Reduced cerebellar neurodegeneration after combined therapy with cyclodextrin/allopregnanolone and miglustat in NPC1: a mouse model of Niemann-Pick type C1 disease.
Maass F; Petersen J; Hovakimyan M; Schmitt O; Witt M; Hawlitschka A; Lukas J; Rolfs A; Wree A
J Neurosci Res; 2015 Mar; 93(3):433-42. PubMed ID: 25400034
[TBL] [Abstract][Full Text] [Related]
6. Pregnane X receptor (PXR) activation: a mechanism for neuroprotection in a mouse model of Niemann-Pick C disease.
Langmade SJ; Gale SE; Frolov A; Mohri I; Suzuki K; Mellon SH; Walkley SU; Covey DF; Schaffer JE; Ory DS
Proc Natl Acad Sci U S A; 2006 Sep; 103(37):13807-12. PubMed ID: 16940355
[TBL] [Abstract][Full Text] [Related]
7. Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression.
Davidson CD; Ali NF; Micsenyi MC; Stephney G; Renault S; Dobrenis K; Ory DS; Vanier MT; Walkley SU
PLoS One; 2009 Sep; 4(9):e6951. PubMed ID: 19750228
[TBL] [Abstract][Full Text] [Related]
8. Enhanced anticonvulsant activity of ganaxolone after neurosteroid withdrawal in a rat model of catamenial epilepsy.
Reddy DS; Rogawski MA
J Pharmacol Exp Ther; 2000 Sep; 294(3):909-15. PubMed ID: 10945840
[TBL] [Abstract][Full Text] [Related]
9. Allopregnanolone treatment, both as a single injection or repetitively, delays demyelination and enhances survival of Niemann-Pick C mice.
Ahmad I; Lope-Piedrafita S; Bi X; Hicks C; Yao Y; Yu C; Chaitkin E; Howison CM; Weberg L; Trouard TP; Erickson RP
J Neurosci Res; 2005 Dec; 82(6):811-21. PubMed ID: 16273542
[TBL] [Abstract][Full Text] [Related]
10. Revisiting the roles of progesterone and allopregnanolone in the nervous system: resurgence of the progesterone receptors.
Schumacher M; Mattern C; Ghoumari A; Oudinet JP; Liere P; Labombarda F; Sitruk-Ware R; De Nicola AF; Guennoun R
Prog Neurobiol; 2014 Feb; 113():6-39. PubMed ID: 24172649
[TBL] [Abstract][Full Text] [Related]
11. Decreased estradiol release from astrocytes contributes to the neurodegeneration in a mouse model of Niemann-Pick disease type C.
Chen G; Li HM; Chen YR; Gu XS; Duan S
Glia; 2007 Nov; 55(15):1509-18. PubMed ID: 17705200
[TBL] [Abstract][Full Text] [Related]
12. Allopregnanolone and pregnanolone analogues modified in the C ring: synthesis and activity.
Slavíková B; Bujons J; Matyáš L; Vidal M; Babot Z; Krištofíková Z; Suñol C; Kasal A
J Med Chem; 2013 Mar; 56(6):2323-36. PubMed ID: 23421641
[TBL] [Abstract][Full Text] [Related]
13. Allopregnanolone as regenerative therapeutic for Alzheimer's disease: translational development and clinical promise.
Irwin RW; Brinton RD
Prog Neurobiol; 2014 Feb; 113():40-55. PubMed ID: 24044981
[TBL] [Abstract][Full Text] [Related]
14. Normalization of Hepatic Homeostasis in the
Munkacsi AB; Hammond N; Schneider RT; Senanayake DS; Higaki K; Lagutin K; Bloor SJ; Ory DS; Maue RA; Chen FW; Hernandez-Ono A; Dahlson N; Repa JJ; Ginsberg HN; Ioannou YA; Sturley SL
J Biol Chem; 2017 Mar; 292(11):4395-4410. PubMed ID: 28031458
[TBL] [Abstract][Full Text] [Related]
15. 3
Chuang SH; Reddy DS
J Pharmacol Exp Ther; 2018 Jun; 365(3):583-601. PubMed ID: 29602830
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic Treatment Assigned for Niemann Pick Type C1 Disease Partly Changes Behavioral Traits in Wild-Type Mice.
Schlegel V; Thieme M; Holzmann C; Witt M; Grittner U; Rolfs A; Wree A
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834854
[TBL] [Abstract][Full Text] [Related]
17. Combined therapy with cyclodextrin/allopregnanolone and miglustat improves motor but not cognitive functions in Niemann-Pick Type C1 mice.
Hovakimyan M; Maass F; Petersen J; Holzmann C; Witt M; Lukas J; Frech MJ; Hübner R; Rolfs A; Wree A
Neuroscience; 2013 Nov; 252():201-11. PubMed ID: 23948640
[TBL] [Abstract][Full Text] [Related]
18. Imatinib therapy blocks cerebellar apoptosis and improves neurological symptoms in a mouse model of Niemann-Pick type C disease.
Alvarez AR; Klein A; Castro J; Cancino GI; Amigo J; Mosqueira M; Vargas LM; Yévenes LF; Bronfman FC; Zanlungo S
FASEB J; 2008 Oct; 22(10):3617-27. PubMed ID: 18591368
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the discriminative stimulus effects of the neuroactive steroid pregnanolone in DBA/2J and C57BL/6J inbred mice.
Shannon EE; Porcu P; Purdy RH; Grant KA
J Pharmacol Exp Ther; 2005 Aug; 314(2):675-85. PubMed ID: 15857945
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiological In Vitro Profile of Neuronal Differentiated Cells Derived from Niemann-Pick Disease Type C2 Patient-Specific iPSCs Carrying the
Liedtke M; Völkner C; Jürs AV; Peter F; Rabenstein M; Hermann A; Frech MJ
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
